↓ Skip to main content

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
2 patents

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
106 Mendeley